Skip to content
School of Pharmacy

expertise: Pharmacy Practice

(including: Management, Safety, Standards, Community Pharmacy practice, Compensation for Clinical Services, Health Systems)(Community Pharmacy practice, Compensations for Clinical Services, Pharmacy Practice Health Systems)

Clayton English

Education:

  • Bachelor of Science in Pharmacy Studies, University of Connecticut
  • Doctor of Pharmacy, University of Connecticut
  • MS in Health Services – Clinical and Translational Research, University of Washington

Research and Clinical Interests:

  • Psychiatric Pharmacy
  • Clinical Psychopharmacology
  • Drug-Induced Disease
  • Deprescribing
  • Mood Disorders
  • Adult ADHD
  • Psychostimulant Use
  • Interprofessional Education

Biography

Dr. Clayton English is an Assistant Professor of Pharmacy at the University of Washington School of Pharmacy. Clayton earned his Bachelor of Science and Doctor of Pharmacy degrees from the University of Connecticut in Storrs, Connecticut and subsequently completed a specialty residency in psychiatric pharmacy practice and clinical psychopharmacology at Nova Southeastern University College of Pharmacy in Fort Lauderdale, Florida. He holds board certifications in Psychiatric Pharmacy (BCPP), Pharmacotherapy (BCPS), and Geriatric Pharmacy (BCGP). From 2010 to 2022, Clayton served as a faculty member at Albany College of Pharmacy and Health Sciences (ACPHS) and practiced as a clinical pharmacy specialist in psychiatry at the University of Vermont Medical Center (UVMMC) in Burlington, Vermont. During his time in Vermont, Clayton helped expand clinical pharmacy services within inpatient psychiatry at UVMMC and precepted and assisted in the training of numerous students and residents in both pharmacy and psychiatry. Additionally, Clayton was highly involved in the didactic instruction of neuropsychiatric therapeutics and psychopharmacology across the pharmacy school curriculum.

Clayton has broad clinical and research interests in neurologic and psychiatric pharmacy including safe and appropriate use of psychiatric medications, psychotropic deprescribing, pharmacovigilance, mood disorders, adult ADHD, and drug-induced behavioral disorders. Additionally, Clayton is passionate about interprofessional education, team-based care, and student and resident well-being.

Clayton remains highly engaged in the professional development of pharmacists and enjoys participating in activities and organizations that advocate for the profession. Clayton is an active member of the American Association of Psychiatric Pharmacists (AAPP) and serves as a Senior Editor for the AAPP Psychiatric Pharmacotherapy Review Book and Course. He has been honored for his contributions to the profession and education of students and residents. He was the recipient of the Award of Excellence in Academic Teaching from the University of Vermont Psychiatry Residency Program in 2012, 2017, and 2019 and was recognized in 2013 as the Vermont Pharmacist of the Year by the Vermont Society of Health-Systems Pharmacists. Additionally, he was recognized as the ACPHS Preceptor of the Year in 2015 and Teacher of the Year of the ACPHS Vermont Campus in 2017 and 2021. Outside the classroom, Clayton enjoys exercising, road trips, spending time with his family, and exploring the greater Seattle area for the best coffee around.

Selected Publications

English C, Bode L. Major Depressive Disorder. In: Pharmacotherapy Self-Assessment Program, 2022 Book 3. Behavioral Health. Lenexa, KS: American College of Clinical Pharmacy, 2022.

English C. Depression. In: 2020-2021 Psychiatric Pharmacotherapy Review Course. College of Psychiatric & Neurologic Pharmacists. Lincoln: CPNP; 2020.

English C, Goodwin H, Dickinson JA, Rey JA. Brexanolone: A novel treatment option for postpartum depression. P&T. 2019;44(11):732-736.

Runyan S, Gething M, English C, Rabinowitz T. Pharmacotherapeutics. In: Fundamentals of Consultation Liaison Psychiatry: Neuropsychiatry. 1st ed. Nova Science Pub Inc; 2019.

DiSciullo AA, English CD, Horn WT. Modafinil Induced Psychosis in a Patient with Bipolar 1 Depression. Case Reports in Psychiatry. 2018;2018:3.

English CD. New therapeutic options for the management of ADHD. US Pharm. 2018;43(5):1-10.

Boyd JT, English C, Lounsbury KM. Antiparkinson Drugs. In: Dowd FJ, Johnson BS, Mariotti AJ. Pharmacology and Therapeutics for Dentistry. 7th ed. St. Louis: Elsevier; 2017.

English C, Aloi JJ. New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis.
Clin Ther. 2015;37(4):691-715.

Harrington CA, English C, Schaefer S. Systematic review of the post-marketing surveillance of paliperidone. Journal of Symptoms and Signs. 2014;3(1):39-49.

English C, Rey JA, Schlesselman LS. Prevalence of hazardous alcohol use among pharmacy students at nine U.S. schools of pharmacy. Pharmacy Practice (Internet) 2011 Jul-Sep;9(3):162-168.

Harrington CA, English C. Adverse drug events related to ziprasidone: a meta-analysis of randomized, placebo-controlled trials. Pharmacotherapy 2011;31(9):840-849.

Sharon Wu

Education

  • BA in Molecular & Cell Biology, University of California, Berkeley
  • PharmD, University of California, San Diego
  • PGY-1 Pharmacy Practice Residency, UW Medicine
  • PGY-2 Ambulatory Care and Academia Residency, Pacific University SOP/Virginia Garcia Memorial Health Center

Courses Taught

  • PHRMCY 544-546: Pharmacist Provider Readiness IV-VI
  • PHRMPR 532: Pharmacist Provider Experience Year II
  • PHRMCY 551: Case Conferences and Continuous Professional Development
  • PHRMCY 534: Pharmacotherapeutics (Asthma and Osteoarthritis)

Biography

Dr. Wu is an Associate Teaching Professor with experience teaching and coordinating courses in diverse areas, including Endocrine, Immunology, and Pulmonology. She currently serves as a co-course director for the PY2 Pharmacist Provider Series, which focuses on developing communication and clinical reasoning skills in both the skills lab and experiential settings to support outpatient and ambulatory care. In addition, she is a co-course director for the fourth-year longitudinal Continuous Professional Development course.

Dr. Wu is a Board Certified Ambulatory Care Pharmacist with experience managing underserved patients with chronic conditions, including diabetes, hypertension, cardiovascular risk, and asthma/COPD. Her clinical interests include diabetes, pulmonology, and solid organ transplantation, and her scholarship focuses on teaching and learning in pharmacy education, health and wellness, professional identity formation, and reimbursement for pharmacy services.

Dr. Wu serves as Faculty Director of the UWSOP STEP Program for high school students and as the 2025-2026 Chair of the School’s Academic Progress Committee. She also serves on various national committees and task forces within the American Association of Colleges of Pharmacy (AACP) and the American College of Clinical Pharmacy (ACCP).

Jennifer Bacci

Education:

  • PharmD, University of Pittsburgh School of Pharmacy
  • MPH, University of Pittsburgh School of Public Health

Research Interests:

  • Community-based pharmacy practice
  • Implementation science
  • Prevention and public health

Courses Taught: 

  • PHRMCY 501: Foundations of Being a Pharmacist I
  • PHRMCY 502: Foundations of Being a Pharmacist II
  • PHARM 523: Insights into Community Pharmacy Practice Transformation

Biography: 

Dr. Bacci is the Endowed Associate Professor of Innovative Pharmacy Practice at the University of Washington School of Pharmacy. Her research focuses on the application of implementation science to evaluate and advance the adoption of innovative patient care models in community pharmacy practice, including childhood and adult vaccinations, point-of-care testing, chronic disease management, pharmacist prescribing, and medical billing. Dr. Bacci collaborates closely with community partners to address needs and challenges faced by practitioners and patients and amplify the positive impact of community-based pharmacy teams.

Dr. Bacci practiced in community pharmacy for 10 years in chain and independent settings and is a Board Certified Ambulatory Care Pharmacist (BCACP). She remains highly engaged in practice as a member of the Washington State Pharmacy Association (WSPA) Board of Directors, a Network Facilitator for CPESN WA, a clinically integrated network of independent pharmacies in Washington State, and as a leader in the Academia-Community Transformation (ACT) Pharmacy Collaborative, a nationwide collaboration to support and facilitate community pharmacy practice transformation efforts.

Dr. Bacci has been honored with the 2021 Albert B. Prescott Pharmacy Leadership Award and 2019 Washington State Distinguished Young Pharmacist of the Year Award. Dr. Bacci and her research collaborators have been recognized with the 2018 NAIIS “Immunization Neighborhood” Adult Immunization Champion Award and 2018 American Pharmacist Association Immunization Champion Award.

Dr. Bacci completed her PharmD at PittPharmacy in 2011 followed by followed by a PGY-1 Community-based Pharmacy Residency with PittPharmacy and Rite Aid. After working full-time in community practice, she returned to PittPharmacy to complete a two-year Community Pharmacy Research Fellowship.

Selected Publications:

Wittenauer R, Shah PD, Bacci JL, Stergachis A. Locations and characteristics of pharmacy deserts in the United States: a geospatial study. Health Aff Sch. 2024;2(4):qxae035. Published 2024 Mar 16. doi:10.1093/haschl/qxae035

Bacci JL, English C, Odegard PS, Stergachis A, Snyder CR, Danielson JH. A 2023 Washington State pharmacist workforce survey: Employment and patient care roles. J Am Pharm Assoc (2003). 2025;65(1):102314. doi:10.1016/j.japh.2024.102314

Bacci JL, Nwogu IB, Zaraa S, et al. A community pharmacist intervention for people living with epilepsy. J Am Pharm Assoc (2003). 2025;65(1):102275. doi:10.1016/j.japh.2024.102275

Bhardwaj S, Galanter N, Berenbrok LA, Shah PD, Bacci JL. Pediatric vaccination in pharmacies is not associated with delayed well-child visits among commercially insured children. Health Aff Sch. 2025;3(2):qxaf028. Published 2025 Feb 10. doi:10.1093/haschl/qxaf028

Bacci JL, Marcum ZA, Rodriguez P, et al. Community pharmacist intervention to optimize statin adherence in diabetes care: The GuIDE-S study. J Am Pharm Assoc. 2023;63(3):946-951. doi:10.1016/j.japh.2023.03.002

Bacci JL, Rodriguez T, Hansen R, et al. Community pharmacist intervention to close statin gaps in diabetes care: The GuIDE-S study. J Am Pharm Assoc. 2023;63(1):108-117. doi:10.1016/j.japh.2022.08.025

Bacci JL, Coley K, Daly C, et al. Qualitative analysis of community pharmacy practice transformation. J Am Coll Clin Pharm. 2022; 5(12):1236-1252. doi:10.1002/jac5.1728

Bacci JL, Odegard P, Arnold J, Stergachis A. Strengthening pandemic preparedness through pharmacy and public health collaborations: Findings from a facilitated discussion exercise. J Am Pharm Assoc. 2021;61(3):e99-e106. doi:10.1016/j.japh.2020.12.024

Bacci JL, Zaraa S, Stergachis A, Simic G, White HS. Community pharmacists’ role in caring for people living with epilepsy: A scoping review. Epilepsy Behav. 2021;117:107850. doi:10.1016/j.yebeh.2021.107850

Bacci JL, Hansen R, Ree C, Reynolds MJ, Stergachis A, Odegard PS. The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists. Vaccine. 2019;37(1):152-159. doi:10.1016/j.vaccine.2018.11.018

Wang AB, Bacci JL, Amoo M, Ree C, Firebaugh R, Odegard P. Impact of an immunization platform in community pharmacies. J Am Pharm Assoc. 2019;59(4S):S151-S155. doi:10.1016/j.japh.2019.05.007

Akers JL, Meer G, Kintner J, Shields A, Dillon-Sumner L, Bacci JL. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships. J Am Pharm Assoc. 2019;59(2):243-251. doi:10.1016/j.japh.2018.11.008

 

 

Jennifer Chang

Education

  • Bachelor of Science in Pharmaceutical Sciences, University of British Columbia.
  • Doctor of Pharmacy, University of Minnesota.
  • PGY-1 Pharmacy Practice Residency, UW Medicine
  • Board Certified Pharmacotherapy Specialist (BCPS)

Research Interests

  • Patient safety and quality improvement
  • Pharmacy Education (Scholarship of Teaching and Learning)
  • Experiential Education

Courses Taught

  • PHRMCY 513: Applied Patient Safety and Quality
  • PHRMCY 541-542-543: Pharmacist Provider Readiness I, II, III
  • PHRMPR 511-512-513: Pharmacist Provider Experience I, II, III
  • PHRMPR 541: Introductory Pharmacy Practice Experience in Institutional Health-System
  • PHARM 594: Pharmacy Practice VI Medication Safety and Quality
  • PHARM 593: Pharmacy Practice V Institutional Practice

Biography

Dr. Jennifer Chang is an Associate Teaching Professor at the University of Washington (UW) School of Pharmacy. Her professional interests include patient safety and quality, institutional practice, and scholarship of teaching and learning in the areas of skill development and experiential education. She provided leadership and oversight in the design and implementation of the new Pharmacist Provider Series (PPS) in the PharmD curriculum. Dr. Chang collaborates closely with practice experts and faculty to design and coordinate student learning experiences on- and off-campus to ensure student readiness for practice. Dr. Chang earned her Bachelor of Science in Pharmaceutical Sciences degree from the University of British Columbia in 1995 and her Post-Baccalaureate Doctor of Pharmacy degree from the University of Minnesota in 1997. She completed her PGY-1 residency training at the University of Washington in 1998 and is a Board Certified Pharmacotherapy Specialist (BCPS). Dr. Chang has held a variety of positions in the health systems setting, including roles in clinical practice, pharmacy administration, medication safety, and pharmacist education. Dr. Chang currently teaches in the PY1 PPS course series with the PY1 PPS faculty team and serves as a co-course master for the Applied Patient Safety and Quality course. She also serves as a Co-Director for the UW School of Pharmacy Teaching and Learning Certificate Program. She enjoys precepting and mentoring students as well as PGY1 residents. Dr. Chang and the PY1 PPS Team have been honored with the 2023 UW Distinguished Teaching Award for Teams and the 2021 UW School of Pharmacy First Professional Year Excellence in Teaching Award.